METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE

KVK-Tech, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 16, 2024
Approval ID: be8580bc-0eb2-4eb6-a4cc-4ebbeb33424d
Products: 2 registered
Version: 11

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Tablets USP CII safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Tablets USP CII. Methylphenidate hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 1955

Quick Stats

Total Products2

Labelers2

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.